Efficacy, tolerability, and immunogenicity of botulinum toxin A for torticollis.

Trial Profile

Efficacy, tolerability, and immunogenicity of botulinum toxin A for torticollis.

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Sep 2012

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Torticollis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Sep 2012 New trial record
    • 31 Aug 2012 The primary endpoints Cervical Dystonia Severity Scale and Physician Global Assessment have been met.
    • 31 Aug 2012 Results published in the Clinical Neuropharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top